| Authors: |
Pritzl SL; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN., Vierkant RA; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Ruddy KJ; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN., Stan DL; Department of General Internal Medicine, Mayo Clinic, Rochester, MN., Larson NL; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Olson JE; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Couch FJ; Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Higgins AS; Avera Medical Group Oncology & Hematology, Avera Health, Sioux Falls, SD., Ehlers SL; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN. |
